Perugia, Italy

Enrico Tiacci

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Enrico Tiacci: Innovator in Hairy Cell Leukemia Research

Introduction

Enrico Tiacci is a notable inventor based in Perugia, Italy, known for his significant contribution to the field of oncology. His groundbreaking work has led to the development of innovative methods for diagnosing and treating hairy cell leukemia.

Latest Patents

Tiacci holds one patent titled "Method for monitoring minimal residual hairy cell leukemia." This invention focuses on biomarkers related to hairy cell leukemia and outlines methods for utilizing these biomarkers to enhance diagnosis and treatment options. His work represents a major advancement in the way this specific type of leukemia can be monitored and managed.

Career Highlights

Enrico Tiacci is associated with Trovagene, Inc., a company that specializes in the development of non-invasive molecular diagnostics. His expertise in the field of cancer research has been instrumental in furthering the understanding of hairy cell leukemia and developing effective treatment strategies. His work has positioned him as a key figure in this critical area of medical research.

Collaborations

Throughout his career, Tiacci has collaborated with esteemed colleagues, including Brunangelo Falini and Raul Rabadan. This collaboration has fostered a rich exchange of ideas and knowledge, further pushing the boundaries of research in leukemia and cancer treatment.

Conclusion

Enrico Tiacci's work, particularly in the context of monitoring hairy cell leukemia, highlights the importance of innovation in medical research. His patent is a testament to the significant strides being made in the field, bringing hope for better diagnostic and treatment methods for patients suffering from this devastating illness. Tiacci's ongoing contributions to Trovagene, Inc. and collaboration with prominent researchers continue to pave the way for advancements in oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…